Sign up to our newsletter Subscribe
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

COVID-19 presents numerous ongoing challenges. Research continues into vaccines and antivirals, as well as the known and unknown effects of long covid on individual health and society more broadly. There have also been challenges with access and reimbursement in low and middle-income countries.